Lifewardの空売り状況は、投資家がLifewardの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Lifeward (NASDAQ:LFWD) 株価情報, 空売り情報

Lifeward

Rewalk Robotics

Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.

Lifeward Ltd

U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 100 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 0.08% to 44,590.52 while the NASDAQ fell 0.55% to 19,545.97. The S&amp;P 500 also fell, dropping, 0.17% to 6,027.54.
Check This Out: <a href="https://www.benzinga.com/25/02/43490310/top-2-health-care-stocks-that-may-crash-in-february">Top 2 Health Care Stocks That May Crash In February</a>
Leading and Lagging Sectors Utilities shares surged by 1.1% on Wednesday.
In trading on Wednesday, communication services shares fell by 2.6%.
Top Headline
The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) reported better-than-expected first-quarter financial results.
Walt Disney reported quarterly earnings of $1.76 per share which beat the analyst consensus estimate of $1.45 per share. The company reported quarterly sales of $24.70 billion which beat the analyst consensus estimate of $24.62 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Oragenics Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#NYSE">OGEN</a>) shares shot up 94% to $0.55.</li>
<li>Shares of Pasithea Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>)got a boost, surging 59% to $3.32 after a Safety Review Committee recommended proceeding to Cohort 5 in its Phase 1 trial of PAS-004 without modification.</li>
<li>Aurora Cannabis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares were also up, gaining 41% to $5.18 after the company reported a 37% YoY increase in third-quarter total net revenue.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Volcon Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) shares dropped 39% to $1.96 after the company announced the pricing of $12.0 million underwritten public offering.</li>
<li>Shares of FMC Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) were down 36% to $34.70 following weak guidance.</li>
<li>Lottery.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRY#NASDAQ">LTRY</a>) was down, falling 29% to $0.42. Lottery.com recently announced an international operations expansion by targeting Europe, Africa, and other emerging markets.</li>
</ul>
Commodities In commodity news, oil traded down 1.2% to $71.86 while gold traded up 0.5% at $2,889.50.
Silver traded down 0.4% to $32.880 on Wednesday, while copper rose 0.2% to $4.3620.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 rose 0.2%, Germany's DAX 40 slipped 0.1% and France's CAC 40 fell 0.2%. Spain's IBEX 35 Index rose 1.2%, while London's FTSE 100 rose 0.2%.
Asia Pacific Markets
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei 225 gaining 0.09%, China's Shanghai Composite Index falling 0.65%, Hong Kong's Hang Seng Index falling 0.93% and India's BSE Sensex falling 0.40%.
Economics
<ul>
<li>The U.S. trade deficit increased to $98.4 billion in December versus a revised $78.9 billion gap in the previous month and compared to market estimates of a $96.6 billion gap.</li>
<li>U.S. private businesses added 183,000 workers to their payrolls in January, compared to a revised 176,000 gain in December and above expectations of 150,000.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43491430/wall-streets-most-accurate-analysts-spotlight-on-3-industrials-stocks-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Industrials Stocks Delivering High-Dividend Yields</a></li>
</ul>

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

KTTA

LTRY

OGEN

VLCN

US Stocks Mixed; Walt Disney Posts Upbeat Earnings

Jefferies analyst Omar Nokta maintains Costamare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMRE#NYSE">CMRE</a>) with a Hold and maintains $13 price target.

Price Target

Analyst Ratings

CMRE

Jefferies Maintains Hold on Costamare, Maintains $13 Price Target

Toyota Motor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) has unveiled a major partnership with the Shanghai municipal government to <a href="https://global.toyota/en/newsroom/corporate/42193101.html">support carbon neutrality efforts</a>. 
This collaboration will concentrate on key areas such as hydrogen energy, self-driving technology and battery recycling.
As part of the agreement, the company will set up a fully-owned subsidiary in Jinshan District, Shanghai, to address the increasing demand for new energy vehicles in China.
Toyota&#8217;s upcoming subsidiary will be central to manufacturing battery electric vehicles (BEVs) and batteries. 
The company plans to introduce a new Lexus BEV model, with production slated for 2027. At the outset, the facility is expected to produce 100,000 units annually, while also creating approximately 1,000 jobs during its initial phase of operation.
Also Read: <a href="https://www.benzinga.com/news/management/25/02/43429256/jeep-maker-stellantis-unveils-organizational-overhaul-stock-dips">Jeep Maker Stellantis Unveils Organizational Overhaul</a>
Toyota sold over a million electrified vehicles in the U.S., including nearly 900,000 Toyota brand vehicles and over 100,000 Lexus brand vehicles, marking a <a href="https://www.benzinga.com/tech/25/01/42809131/toyota-overtakes-ford-gm-in-ev-sales-in-us-thanks-to-its-hybrid-vehicle-lineup">growth of over 50% year-on-year</a>.
The company retained its position as the world's best-selling automaker in 2024 with 10.8 million sales, out of which <a href="https://www.benzinga.com/tech/25/01/43380849/toyota-retains-top-selling-automaker-position-while-continuing-to-trail-tesla-byd-in-ev-sales">4.5 million were electrified vehicles</a>.
Electrified vehicles encompass a range of types, including hybrid, plug-in hybrid, battery electric, mild hybrid and fuel-cell electric vehicles.
The company raised its full-year operating income forecast by 400 billion yen ($2.62 billion), bringing the total to 4,700 billion yen for the fiscal year ending in March 2025.
Toyota&#8217;s latest initiative supports China&#8217;s ambition to reach net-zero emissions by 2060. Through established collaborations with major local players like China FAW Group Co. and Guangzhou Automobile Group Co., Toyota aims to enhance its footprint, offering environmentally friendly solutions while playing a key role in China&#8217;s shift toward sustainability.
Price Action: TM shares are trading higher by 2.63% at $192.50 in premarket at the last check Wednesday.
Read Next: <a href="https://www.benzinga.com/25/02/43463646/alcohol-giant-diageo-suspends-guidance-as-trumps-tariff-looms">Alcohol Giant Diageo Suspends Medium-Term Guidance As Trump&#8217;s Tariff Looms</a>
Photo: Shutterstock

General

Toyota To Open New EV Production Facility In Shanghai

Barrington Research analyst Alexander Paris maintains H&amp;R Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRB#NYSE">HRB</a>) with a Outperform and maintains $70 price target.

Barrington Research Maintains Outperform on H&R Block, Maintains $70 Price Target

VCIG

VCI Global Limited Announces The Development Of A Next-Generation AI Aggregator Platform. Designed to Streamline AI Integration

Chinese e-commerce giant&nbsp;JD.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) shares are trading lower in the<a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener"> premarket session on Wednesday.</a>
The company is in the headlines today for reportedly reviving its interest in buying Düsseldorf, Germany-based Ceconomy AG, Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-02-05/jd-com-is-said-to-revive-interest-in-buying-germany-s-ceconomy" target="_blank" rel="noreferrer noopener">reports</a>.
This is not the first time, when JD.com showed interest in the German retailer. Earlier in 2023, it expressed interest in Ceconomy.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, JD has gained over 80% in the past year.
This time, JD.com is aiming for deal and has approached shareholders of the German company, Bloomberg adds, citing people familiar with the discussions.
Apart from the Ceconomy update, JD.com had been in the news last year for announcing in that it would not proceed with a previously considered cash offer for UK-based Currys.
See Also:&nbsp;<a target="_blank" href="https://www.benzinga.com/25/02/43480859/trump-confirms-maximum-economic-pressure-on-iran-calls-chinas-tariff-retaliation-fine" rel="noreferrer noopener">Trump Confirms Maximum Economic Pressure On Iran, Calls China's Tariff Retaliation ‘Fine'</a>
In a <a target="_blank" href="https://www.londonstockexchange.com/news-article/0JOQ/statement-from-jd-com/16380661" rel="noreferrer noopener">filing </a>to the London Stock Exchange, the company cited &#8220;careful&#8221; consideration as the reason behind its decision to back away from the transaction, after initially exploring the potential move in early 2024.
Meanwhile, JD.com&#8217;s relationship with Walmart has also evolved.
After eight years of partnership, Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) last year sold its entire stake in JD.com, worth up to $3.74 billion, to refocus on its operations in China.
The two companies began their collaboration in 2016 when Walmart sold its Yihaodian grocery store to JD.com in exchange for a 5% stake, valued at around $1.5 billion at the time.
As JD.com explores its next moves, investors looking to gain exposure to the company can do so through the Invesco Golden Dragon China ETF (PGJ), which includes JD.com in its portfolio.
While JD.com&#8217;s stock has seen a slight dip in premarket trading, the company&#8217;s ongoing strategic shifts reflect its ambitious plans for growth and expansion in global markets.
Price Action: JD shares are trading lower by 2.84% to $40.14 premarket at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43468887/robert-f-kennedy-nomination-advances-to-full-senate-vaccine-stocks-drop" target="_blank" rel="noreferrer noopener">Robert F. Kennedy's Health Secretary Nomination Advances To Full Senate: Vaccine Stocks Drop</a></li>
</ul>
Image: Shutterstock

Movers

JD.com's Stock Dips As Ceconomy Deal Heats Up In Germany: Is the E-Commerce King Eyeing Expansion?

Stephens &amp; Co. analyst Jim Salera maintains Lancaster Colony (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LANC#NASDAQ">LANC</a>) with a Equal-Weight and raises the price target from $196 to $200.

LANC

Stephens & Co. Maintains Equal-Weight on Lancaster Colony, Raises Price Target to $200

BWS Financial analyst Hamed Khorsand maintains Immersion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMR#NASDAQ">IMMR</a>) with a Buy and maintains $13.5 price target.

IMMR

BWS Financial Maintains Buy on Immersion, Maintains $13.5 Price Target

XAIR

Beyond Air Receives Notification From Nasdaq Stating That The Company Has Been Granted An Additional 180-Day Compliance Period, Or Until August 4, 2025 To Regain Compliance With Nasdaq's Minimum Bid Price Rule

Baird analyst Andrew Wittmann maintains Jacobs Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>) with a Outperform and lowers the price target from $154 to $148.

Baird Maintains Outperform on Jacobs Solutions, Lowers Price Target to $148

BWS Financial analyst Hamed Khorsand maintains A10 Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATEN#NYSE">ATEN</a>) with a Buy and maintains $24 price target.

ATEN

BWS Financial Maintains Buy on A10 Networks, Maintains $24 Price Target

WIIM

SMCI

Super Micro Computer shares are trading higher after the company announced the full production of NVIDIA Blackwell rack-scale solutions with NVIDIA HGX B200.

<a href="https://www.sec.gov/Archives/edgar/data/715153/000119312525020499/d878946d6k.htm" title="https://www.sec.gov/Archives/edgar/data/715153/000119312525020499/d878946d6k.htm">https://www.sec.gov/Archives/edgar/data/715153/000119312525020499/d878946d6k.htm</a>

NSANY

Honda Motor Reports On Integration Of Management Between Nissan Motor & Honda Says Nissan & Co Are In Stage Of Advancing Various Discussions

IVVD

Invivyd Announces A Strategic Partnership With Professional Football Coach Jim Harbaugh To Raise Awareness About the Ongoing Short And Potential Long-Term Risks of COVID-19 To The Broad Population

Baird analyst Ghansham Panjabi maintains Graphic Packaging Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPK#NYSE">GPK</a>) with a Outperform and lowers the price target from $36 to $32.

Baird Maintains Outperform on Graphic Packaging Holding, Lowers Price Target to $32

Telsey Advisory Group analyst Dana Telsey maintains Capri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) with a Market Perform and maintains $23 price target.

CPRI

Telsey Advisory Group Maintains Market Perform on Capri Holdings, Maintains $23 Price Target

Canada-based global medical cannabis company&nbsp;Aurora Cannabis Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) reported a third-quarter fiscal 2025 net revenue of CA$88.2 million, compared to&nbsp;CA$64.4 <a target="_blank" href="https://www.benzinga.com/quote/ACB" rel="noreferrer noopener">million a year ago</a>.
The 37% increase from the prior period was mainly due to 51% growth in the global medical cannabis business and 22% in the plant propagation business, slightly offset by lower quarterly revenue in the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43490408/aurora-cannabis-announces-fiscal-2025-third-quarter-results" rel="noreferrer noopener">consumer cannabis business</a>.
Consolidated adjusted gross margin was 65% in the third quarter and 53% in the prior-year quarter. Adjusted gross profit was&nbsp;CA$56.0 million&nbsp;in the third quarter vs.&nbsp;CA$33.6 million&nbsp;in the prior year quarter, an increase of 67%.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/01/43195749/the-week-in-cannabis-trumps-dea-pick-tysons-reform-push-dutch-coffee-shop-crisis-and-more" rel="noreferrer noopener">The Week In Cannabis: Trump&#8217;s DEA Pick, Tyson&#8217;s Reform Push, Dutch Coffee Shop Crisis And More</a>
Medical cannabis net revenue was CA$68.1 million, a 51% increase from the prior-year quarter, driven by CA$23.1 million was primarily due to higher sales to Australia, Germany, Poland and the UK, as well as increased revenue in Canada to insurance covered and self-paying patients.
The adjusted gross margin reached 74%, compared to 63% in the prior year quarter, through sustainable cost reductions, higher selling prices, and improved efficiency in production operations, including sourcing for&nbsp;Europe&nbsp;from&nbsp;Canada.
Aurora&#8217;s consumer cannabis net revenue&nbsp;was&nbsp;CA$9.9 million, a 15% decrease compared to&nbsp;$11.6 million&nbsp;in the prior year quarter, mainly due to the decision to prioritize the supply of GMP manufactured products to high-margin global medical cannabis business rather than the consumer business, which offers lower margins.
Plant propagation net revenue contributed&nbsp;$8.9 million, a 22% increase compared to&nbsp;$7.3 million&nbsp;a year ago, due to organic growth and expanded product offerings arising from increased capacity.
Adjusted EBITDA&nbsp;increased 316% to&nbsp;CA$23.1 million&nbsp;compared to&nbsp;CA$5.5 million&nbsp;a year ago.
&#8220;This quarter was record-breaking for Aurora, driven by all-time highs in global medical net revenue, net income, adjusted EBITDA, and free cash flow,&#8221; said Miguel Martin, executive chairman and CEO for Aurora Cannabis.
Fiscal Q4 2025 Expectations:
<ul>
<li>Revenue is expected to grow, driven by international medical cannabis sales.</li>
<li>Seasonal increase in plant propagation revenue, following usual trends.</li>
<li>Strong profit margins and continued positive adjusted EBITDA.</li>
<li>Lower operating cash use due to disciplined spending and revenue growth.</li>
<li>Free cash flow should be slightly positive as cash use improves.</li>
</ul>
Price Action: ACB stock is up 31.3% at $4.83 during the premarket session at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43491991/novo-nordisk-records-more-than-double-wegovy-sales-in-q4-seeks-regulatory-approval-for-hybrid-weight-loss-drug-in-2026" target="_blank" rel="noreferrer noopener">Novo Nordisk Q4 Earnings: Wegovy Sales More Than Double, Seeks Regulatory Approval For Hybrid Weight Loss Drug In 2026</a></li>
</ul>

Cannabis

Guidance

Aurora Cannabis Stock Jumps On 'Record-Breaking' Q3 Earnings

BBAI

BigBear.Ai shares are trading higher after the company announced a contract by the DOD's chief digital and artificial intelligence office.

Baird analyst David Leiker maintains Cummins (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) with a Neutral and raises the price target from $395 to $407.

Baird Maintains Neutral on Cummins, Raises Price Target to $407

Beyond Air Granted 180-Day Extension To Regain Nasdaq Compliance

An update from Rewalk Robotics (LFWD) is now available. At ReWalk Robotics Ltd.'s 2024 Annual Meeting, shareholders approved the reelection of Hada...

ReWalk Robotics Approves Directors and Company Renaming at Annual Meeting

ReWalk Robotics finalizes name change to Lifeward

Lifeward launches direct sales of AlterG product line in Germany

The latest announcement is out from Rewalk Robotics ( ($LFWD) ). Lifeward Ltd. has expanded its Board of Directors by appointing Robert J. Marshall...

Rewalk Robotics Welcomes Robert J. Marshall Jr. to Board

Here's the major earnings before the open tomorrow

Lifeward Ltd. (LFWD) Q3 2024 Earnings Call Transcript

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Rewalk Robotics (LFWD – Research Report), with a...

Rewalk Robotics: Strong Revenue Growth and Strategic Developments Justify Buy Rating

Lifeward (LFWD) applauded the decision by the government of Hungary to establish a new state insurance code to provide coverage for exoskeleton tra...

Lifeward announces Hungary expands policy providing access to exoskeletons

Lifeward stock slips on $5M securities offering

Lifeward (LFWD) announced that it has finalized its agreement with BARMER, Germany's second largest statutory health insurer, to formalize the reim...

Lifeward finalizes agreement with BARMER

ACTG

AGEN

AMTX

AUTL

AXSM

BAYZF

BIOX

BITF

BLDE

BWAY

BXSL

CAMT

CBAT

CCLD

CGEN

CRON

CVAC

DAVA

EVGO

FLNG

FOUR

GENI

GLNG

HUYA

KOPN

LEGN

LFWD

MIRM

NSPR

NVAX

ONON

PLUG

RAIL

RGEN

RGTI

ROIV

SATS

SDGR

SFTBY

SHLS

SHOP

SLVM

SOHO

SOHU

SPHR

TIGR

VERI

ZLAB

Management

Press Releases

Lifeward Announces Appointment of Robert J. Marshall to Its Board of Directors

Lifeward Ltd. Reports Third Quarter 2024 Financial Results

Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Financing

Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Lifeward Cancels Its Extraordinary General Meeting of Shareholders

Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities

Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025

Health Care

Contracts

Lifeward Finalizes Personal Exoskeleton Reimbursement Agreement with BARMER, Adding 8.5 Million Covered Lives in Germany

HC Wainwright & Co.

Comments

Lifeward

空売り

Lifeward (NASDAQ:LFWD) 株価情報, 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル